{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urticaria/background-information/causes-trigger-factors/","result":{"pageContext":{"chapter":{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors","depth":2,"htmlHeader":"<!-- begin field fb0bbc65-ccf9-423a-ba34-d603b4e0b8f7 --><h2>What are the causes/trigger factors?</h2><!-- end field fb0bbc65-ccf9-423a-ba34-d603b4e0b8f7 -->","summary":"","htmlStringContent":"<!-- begin item 872e1ec2-da46-4347-973a-11648e15de7e --><!-- begin field d7506ffc-77ab-4c20-87ab-10a451ee9306 --><ul><li><strong>Urticaria is a mast cell-driven disease. </strong><ul><li>The release of histamine and other inflammatory mediators (such as leukotrienes and prostaglandins) from activated mast cells results in the characteristic pruritus, vascular permeability (leading to plasma leakage from the capillary into the skin), and oedema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Moolani, 2016</a>].</li></ul></li><li><strong>Acute urticaria</strong> (urticaria that lasts for less than 6 weeks) is usually a self-limiting, one-off episode [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">NICE, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>]. It can occur spontaneously or in response to a trigger, typically an acute viral infection (especially in children) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Imbalzano, 2016</a>] or an allergic reactions, for example to [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Moolani, 2016</a>]:<ul><li>Certain foods, such as milk, eggs, peanuts, tree nuts, and shellfish.</li><li>Insect bites and stings.</li><li>Contact allergens, such as latex.</li><li>Certain drugs, such as penicillins, aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and vaccinations.</li></ul></li><li><strong>Chronic urticaria</strong> (urticaria that lasts for 6 weeks or longer, typically on most days of the week) can be spontaneous (chronic spontaneous urticaria [CSU]), autoimmune (autoimmune urticaria [AU]), or inducible (chronic inducible urticaria [CINDU]) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].<ul><li><strong>CSU </strong>occurs with no known identifiable external cause. However, symptoms may be aggravated by heat, stress, certain drugs (for example NSAIDs), and infections (for example viral infection and <em>Helicobacter pylori</em> infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Gu, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Imbalzano, 2016</a>].</li><li><strong>AU</strong> is characterized by the presence of immunoglobulin G (IgG) autoantibodies to the high-affinity receptor for IgE (Fc epsilon R1). It accounts for about 30–50% of chronic urticaria cases [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Pan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>] and may be associated with other autoimmune conditions (such as thyroiditis).<ul><li>In European guidelines AU comes under the CSU subtype [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>].</li></ul></li><li><strong>CINDU</strong> occurs in response to a physical stimulus. It can be further classified according to its cause as:<ul><li><strong>Aquagenic urticaria —</strong> itchy weals after skin contact with hot or cold water. </li><li><strong>Cholinergic urticaria —</strong> itchy weals after active or passive warming (for example from exercise or emotion).</li><li><strong>Cold urticaria —</strong> itchy weals after exposure of the skin to cold.</li><li><strong>Heat urticaria —</strong> itchy weals after exposure of the skin to heat. </li><li><strong>Symptomatic dermatographism —</strong> itching and/or burning skin and the development of strip-shaped weals due to shear force acting on the skin.</li><li><strong>Delayed pressure urticaria —</strong><strong> </strong>erythematous skin swelling after the application of sustained pressure (for example after sitting or lying, or due to tight clothing).</li><li><strong>Solar urticaria —</strong><strong> </strong>itchy weals that occur after light (UV and/or visible light) exposure.</li><li><strong>Vibratory angiodema —</strong><strong> </strong>cutaneous swellings immediately after exposure to vibration (for example from use of vibrating tools).</li><li><strong>Contact urticaria —</strong> itchy weals after contact with eliciting agent.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Leech, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Sharma, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Moolani, 2016</a>]</p><!-- end field d7506ffc-77ab-4c20-87ab-10a451ee9306 --><!-- end item 872e1ec2-da46-4347-973a-11648e15de7e -->","topic":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec","topicId":"73ccd3ba-b5a5-4a3c-98b2-d838dd8a3c58","topicName":"Urticaria","slug":"urticaria","lastRevised":"Last revised in March 2020","chapters":[{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d6e4cfbd-5e36-5755-a780-8091e4b5f146","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9dde1c08-758f-55bb-b187-0203ded94048","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3daa7b54-d234-587b-8a56-1bb5cae1efe4","slug":"changes","fullItemName":"Changes"},{"id":"54c42276-0c06-5c18-825f-3c440cb30dfe","slug":"update","fullItemName":"Update"}]},{"id":"5cff12c3-445b-5613-bf5d-dc48effe6502","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"9abed54c-a9ed-58d4-bfce-3f0dddd49698","slug":"goals","fullItemName":"Goals"},{"id":"c2f713b4-e2ec-5e5e-be8f-5c4285be0b6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e829abf6-8412-500f-9425-647958addf97","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"92b040fe-6318-560a-9ae0-6f98a6aa9c09","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2d2f38df-88c4-5895-915d-199eefc9b02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d51180cd-461f-58ad-8f03-20d63965abfb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a5d17f35-ddfe-5931-bfe4-b7dc039baea0","slug":"definition","fullItemName":"Definition"},{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"76d2cc5e-4a3e-5032-8eed-d4010ace1ae7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"507a6931-af71-54ae-a8e7-2b4393c2a41b","slug":"complications","fullItemName":"Complications"},{"id":"091f4740-5801-5ac0-83bd-a7ebbc2a2848","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations"},{"id":"2da7bf77-7798-5632-97d4-64d5463f8cde","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1a1cabda-9d82-5131-8852-db2d844e0b46","fullItemName":"Management","slug":"management","subChapters":[{"id":"f797a7bd-9ca9-523b-8f1e-e2afc927c4ab","slug":"managing-urticaria","fullItemName":"Scenario: Managing urticaria"}]},{"id":"3c7854e6-2fe5-5632-9b63-69f2773b7dd1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"71f6ce5f-ac94-5ef4-9a02-0aa362883a44","slug":"non-sedating-antihistamines","fullItemName":"Non-sedating antihistamines"},{"id":"8888f0f6-7dd8-55fb-afc0-9e5df55b825a","slug":"sedating-antihistamines","fullItemName":"Sedating antihistamines"},{"id":"b8336773-e3de-5ec0-a85b-93fd72ff7869","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"c88fe5a9-a559-5661-9a1f-e0ee93078a4d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e9950b4f-8af1-5d4b-b531-431ac4a731bb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"729aa2a2-070b-51ed-9ecf-c29549914b66","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a30a2a17-7629-5022-a313-848d8264fb35","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6d1c75a-6a3d-5326-97ca-baff36370740","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dd5a897e-e7d5-5c98-88b6-35014f9a5dde","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d27a969-ded2-5d9d-9321-f65e47426edf","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d45859d-1b50-538f-84fa-568f43b5c283","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}